Responses to parliamentary questions
Question from Deputy Ken O’Flynn - PQ 38849-26
Deputy O'Flynn asked how are reimbursement decisions for high-cost orphan medicines are financially planned. Read the HSE response.
From: Communications and public affairs
Published: May 2026
Updated: July 2026
Documents
Question from Deputy Ken O’Flynn - PQ 38849-26
PDF, 455KB, 3 pages
Summary
To ask the Minister for Health how reimbursement decisions for high-cost orphan medicines are financially planned where the HSE does not centrally retain data regarding the number of clinically eligible patients.
This is a beta version - your feedback will help us to improve it